DNL.L

Diurnal Group plc [DNL.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

DNL.L Stock Summary

Earnings have grown 7.16% per last year.

In the last year, shareholders have seen their holdings diluted. Dilution over past year is 22.69%

Earnings are expected to fall -100% next year

DNL.L has less than 1 year of cash runway

In the News

DNL.L Financial details

Company Rating

Buy

Market Cap

Income

-4.07M

Revenue

6.31M

Book val./share

Cash/share

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

20 Mar 2023

P/E

-2.79

Forward P/E

PEG

0.46

P/S

P/B

1.23

P/C

P/FCF

Quick Ratio

8.41

Current Ratio

9.98

Debt / Equity

LT Debt / Equity

EPS (TTM)

-0.04

EPS next Y

EPS next Q

EPS this Y

-11%

EPS next Y

EPS next 5Y

EPS last 5Y

-18.36%

Revenue last 5Y

129.86%

Revenue Q/Q

EPS Q/Q

SMA20

SMA50

SMA100

Inst Own

Inst Trans

ROA

-40%

ROE

-59%

ROC

-0.5%

Gross Margin

78%

Oper. Margin

-405%

Profit Margin

-354%

Payout

Shs Outstand

174.86M

Shs Float

92.8M

Target Price

52W Range

0.0-67.9

52W High

52W Low

RSI

Rel Volume

0.1

Avg Volume

892.48K

Volume

Perf Week

Perf Month

Perf Quarter

Perf Half Y

Beta

0.353444

Volatility

0%, 0%

Prev Close

Price

Change

DNL.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-06-30

Metric	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0	0.02	0.07	0.05	0.03
Net income per share	-0.27	-0.2	-0.04	-0.11	-0.1
Operating cash flow per share	-0.23	-0.22	-0.05	-0.11	-0.11
Free cash flow per share	-0.23	-0.22	-0.05	-0.11	-0.11
Cash per share	0.31	0.15	0.16	0.37	0
Book value per share	0.31	0.18	0.19	0.39	0
Tangible book value per share	0.31	0.17	0.19	0.39	0
Share holders equity per share	0.31	0.18	0.19	0.39	0
Interest debt per share	0	0	0	0	0
Market cap	15.06M	17.05M	26.03M	26M	46.19M
Enterprise value	-2.22M	7.9M	10.59M	-8.04M	0
P/E ratio	-1.03	-1.39	-6.39	-2.59	-2.79
Price to sales ratio	206.35	16.33	4.12	5.95	9.86
POCF ratio	-1.18	-1.24	-5.41	-2.44	-2.46
PFCF ratio	-1.18	-1.24	-5.36	-2.4	-2.44
P/B Ratio	0.89	1.56	1.42	0.69	0
PTB ratio	0.89	1.56	1.42	0.69	0
EV to sales	-30.42	7.57	1.68	-1.84	0
Enterprise value over EBITDA	0.13	-0.55	-2.02	0.7	0
EV to operating cash flow	0.17	-0.58	-2.2	0.75	0
EV to free cash flow	0.17	-0.57	-2.18	0.74	0
Earnings yield	-0.97	-0.72	-0.16	-0.39	-0.36
Free cash flow yield	-0.85	-0.81	-0.19	-0.42	-0.41
Debt to equity	0	0	0	0	0
Debt to assets	0	0	0	0	0
Net debt to EBITDA	1.04	0.64	2.94	2.96	0
Current ratio	3.97	5.35	7.52	9.98	0
Interest coverage	-75.49	0	0	0	1.73K
Income quality	0.87	1.12	1.18	1.06	1.13
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	93.33	6.38	0.46	0.7	0.79
Research and developement to revenue	137.32	8.32	0.73	1.58	2.58
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0.01	0.02	0.01
Capex to revenue	-0.47	-0.06	-0.01	-0.04	-0.03
Capex to depreciation	-2.43	-2.82	-1.8	-6.79	-0.75
Stock based compensation to revenue	11.07	0.79	0.13	0.11	0.08
Graham number	1.35	0.88	0.43	0.97	0
ROIC	-0.85	-1.12	-0.22	-0.27	0
Return on tangible assets	-0.65	-0.92	-0.19	-0.24	0
Graham Net	0.21	0.11	0.14	0.33	0
Working capital	16.84M	10.88M	16.65M	37.39M	0
Tangible asset value	16.87M	10.9M	18.31M	37.47M	0
Net current asset value	16.84M	10.86M	16.62M	37.32M	0
Invested capital	0	0	0	0	0
Average receivables	0	0	0	0	0
Average payables	2.44M	2.15M	976K	1.27M	0
Average inventory	61.5K	397.5K	956.5K	1.43M	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	76.87K	1.87K	440.95	809.65	0
Days of inventory on hand	2.99K	1.1K	678.09	761.39	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0.2	0.83	0.45	0
Inventory turnover	0.12	0.33	0.54	0.48	0
ROE	-0.87	-1.12	-0.22	-0.27	0
Capex per share	0	0	0	0	0

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q4

Metric	2020-09-30	2020-12-31	2021-06-30	2021-12-31	2022-06-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0.02	0	0	0	0
Net income per share	-0.01	0	0	0	0
Operating cash flow per share	-0.01	0	0	0	0
Free cash flow per share	-0.01	0	0	0	0
Cash per share	0	0	0	0	0
Book value per share	0	0	0	0	0
Tangible book value per share	0	0	0	0	0
Share holders equity per share	0	0	0	0	0
Interest debt per share	0	0	0	0	0
Market cap	26M	0	0	0	0
Enterprise value	0	-20.34M	-34.04M	-24.36M	-16.49M
P/E ratio	-6.38	0	0	0	0
Price to sales ratio	16.47	0	0	0	0
POCF ratio	-21.62	0	0	0	0
PFCF ratio	-21.42	0	0	0	0
P/B Ratio	0	0	0	0	0
PTB ratio	0	0	0	0	0
EV to sales	0	0	0	0	0
Enterprise value over EBITDA	0	0	0	0	0
EV to operating cash flow	0	0	0	0	0
EV to free cash flow	0	0	0	0	0
Earnings yield	-0.04	0	0	0	0
Free cash flow yield	-0.05	0	0	0	0
Debt to equity	0	0	0	0	0
Debt to assets	0	0	0	0	0
Net debt to EBITDA	0	0	0	0	0
Current ratio	0	7.45	9.98	7.52	5.23
Interest coverage	0	0	0	0	0
Income quality	1.18	0	0	0	0
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.46	0	0	0	0
Research and developement to revenue	0.73	0	0	0	0
Intangibles to total assets	0	0	0	0	0.01
Capex to operating cash flow	0.01	0	0	0	0
Capex to revenue	-0.01	0	0	0	0
Capex to depreciation	-1.8	0	0	0	0
Stock based compensation to revenue	0.13	0	0	0	0
Graham number	0	0	0	0	0
ROIC	0	0	0	0	0
Return on tangible assets	0	0	0	0	0
Graham Net	0	0	0	0	0
Working capital	0	20.72M	37.39M	29.84M	21.36M
Tangible asset value	0	23.14M	37.47M	29.79M	21.34M
Net current asset value	0	20.71M	37.32M	29.77M	21.33M
Invested capital	0	0	0	0	0
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0	0	0	0	0
Capex per share	0	0	0	0	0

DNL.L Frequently Asked Questions

What is Diurnal Group plc stock symbol ?

Diurnal Group plc is a GB stock and trading under the symbol DNL.L

What is Diurnal Group plc stock quote today ?

Diurnal Group plc stock price is $- today.

Is Diurnal Group plc stock public?

Yes, Diurnal Group plc is a publicly traded company.

Something similar

Top by Market Cap

FB2A.DE

BRK-B

Company Profile

Volume Average 892.48K
Employee 33
CEO Mr. Richard Edward Bungay A.C.A., ACA, B.Sc., BSc
Headquarters Cardiff,GB
IPO Date 2015-12-24
Website https://www.diurnal.co.uk

Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers an oral formulation of hydrocortisone granules in capsules for the treatment of pediatric adrenal insufficiency. It also develops Chronocort, which completed Phase II clinical trials targeting congenital adrenal hyperplasia and adrenal insufficiency. The company's early-stage pipeline products comprise Ditest, a native oral testosterone product, which has completed phase I clinical trial for the treatment of classical hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (triiodothyronine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.